Arrowhead Pharmaceuticals
ARWR
#2102
Rank
NZ$16.50 B
Marketcap
NZ$116.81
Share price
-4.82%
Change (1 day)
144.03%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): NZ$1.60

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ$1.41. In 2025 the company made an earnings per share (EPS) of NZ-$0.01737 an increase over its 2024 EPS that were of NZ-$8.68.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.60-9305.31%
2025NZ-$0.01737-99.8%
2024NZ-$8.68161.39%
2023NZ-$3.3217.36%
2022NZ-$2.8319.85%
2021NZ-$2.3661.9%
2020NZ-$1.46-216.67%
2019NZ$1.25-210.77%
2018NZ-$1.1338.3%
2017NZ-$0.82-64.93%
2016NZ-$2.33-16.25%
2015NZ-$2.7828%
2014NZ-$2.17-3.85%
2013NZ-$2.26-31.58%
2012NZ-$3.30331.82%
2011NZ-$0.76-51.11%
2010NZ-$1.56-79.07%
2009NZ-$7.47-37.68%
2008NZ-$11.98-16.87%
2007NZ-$14.4138.33%
2006NZ-$10.42122.22%
2005NZ-$4.6942.11%
2004NZ-$3.30533.33%
2003NZ-$0.52-99.08%
2002NZ-$56.3825%
2001NZ-$45.1133.33%
2000NZ-$33.83-120%
1999NZ$169.15-400%
1998NZ-$56.38-81.48%
1997NZ-$304.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.17 978.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ-$14.15-1,106.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$13.61 867.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$6.58 367.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ-$3.94-380.25%๐Ÿ‡บ๐Ÿ‡ธ USA